Lund, Sweden - July 3, 2020 - BioInvent International AB`s (publ) (`BioInvent`) (OMXS:BINV) Extraordinary General Meeting (the `EGM`) today resolved to approve the Board of Directors` resolution on a directed share issue of 270,782,606 new shares, authorized the Board of Directors to resolve on a preferential rights issue (repair rights issue) of a maximum of approximately 105.8 million shares to the Company`s existing shareholders and elected Dr. Thomas Hecht as a new Board member. The EGM resolved to approve the Board of Directors` previous resolution on June 9, 2020 on a directed share issue of maximum 270,782,606 shares, whereby the share capital increases by maximum SEK 21,662,608.48....
|
